UNSPSC 51321807: Etofibrate

This classification denotes an anti-lipidemic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 23TF67G79M. European Medicines Agency schedules Etofibrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07321MIG. Etofibrate generally arises in the molecular formula C18H18CLNO5. The term ETOFIBRATE is an International Non-Proprietary Name or INN. ETOFIBRATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

Most nations schedule etofibrate under HS 29333999 and SITC 51574. As of Q4 2014, ETOFIBRATE remains the US FDA Preferred Term for this commodity. Etofibrate bears US NLM identifiers UMLS ID C0059869 and NCI Concept Code C65588. SMILES: Clc1ccc(OC(C)(C)C(=O)OCCOC(=O)c2cccnc2)cc1.

UNSPSC 51321807 Etofibrate, a Commodity code, covers pharmaceutical products supplied to state and local health agencies, fire rescue services, and cooperative purchasing alliances. State and local governments procure under this code primarily as components of advanced life support medication inventories, generic pharmaceutical supply agreements, and pharmacy benefit programs. Issuing bodies include municipal fire departments and rescue services, state health and human services agencies, and multistate cooperative purchasing consortia. The scope spans sealed-bid procurement for emergency medications with strict expiration and delivery requirements, RFI-stage market intelligence gathering on direct-to-manufacturer pharmacy initiatives, and large-scale RFP-driven generic pharmaceutical supply contracts serving multiple state and local facilities.

Recent activity concentrates in Florida and Minnesota with emerging pharmacy-program development in Texas. The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (Bid No. 26-P-00188, IFB, due April 8, 2026) for Tampa Fire Rescue, specifying four emergency medication line items with nine-month minimum shelf life and ten-day delivery, estimated contract value $40,000.00, with SLBE sheltered market designation and 5 percent bid discount available. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP (Minnesota Multistate Cooperative Purchasing Alliance), issued an RFP (S1070000015802, due March 26, 2026) to establish multi-award contracts for generic pharmaceuticals and OTC products distributed across state and local facilities in Minnesota and Oregon, requiring cGMP and DSCSA compliance, relationships with authorized wholesalers, and pricing through multiple net formats, with contract term two years from July 1, 2026. The Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) to explore vendor capacity for direct-to-manufacturer prescription programs serving state employees and agencies outside traditional PBM and GPO channels, positioning this as preliminary market research preceding future formal procurement.